Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19
Keith Sultan(North Shore University Hospital), Arun Swaminath(Northwell Health), Noah Becher(Northwell Health), Burton I. Korelitz(Northwell Health), Anjali Mone(Northwell Health), James David Mackey(Northwell Health), Komal Lakhani(Northwell Health), Jeffrey Abergel(Northwell Health), Laura Durbin(Northwell Health), Arvind J. Trindade(Northwell Health), Richa Bhardwaj(Washington University in St. Louis), Mohammad Abureesh(Northwell Health)
Cited by 1
Related Papers
Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment
|Journal of Clinical and Translational Hepatology|2017|273
Donning a New Approach to the Practice of Gastroenterology: Perspectives From the COVID-19 Pandemic Epicenter
|Clinical Gastroenterology and Hepatology|2020|35
Investigating the Effects of Curing Quality on Key Concrete Pavement Surface Properties
|Transportation Research Record Journal of the Transportation Research Board|2019|13
Chronic Liver Disease Patients have Worse Outcomes and Increased Postoperative Complications After Orthopedic Fractures
|Journal of Clinical Gastroenterology|2019|10
Upper Gastrointestinal Bleed as a Manifestation of Poorly Differentiated Metastatic Squamous Cell Carcinoma of the Lung
|JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH|2017|7